<VariationArchive RecordType="classified" VariationID="810838" VariationName="NC_000011.10:g.62628412_62655064del" VariationType="Deletion" Accession="VCV000810838" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2020-04-06" MostRecentSubmission="2020-04-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="799086" VariationID="810838">
      <GeneList>
        <Gene Symbol="GANAB" FullName="glucosidase II alpha subunit" GeneID="23193" HGNC_ID="HGNC:4138" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62624829" stop="62646613" display_start="62624829" display_stop="62646613" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62392297" stop="62414103" display_start="62392297" display_stop="62414103" Strand="-" />
          </Location>
          <OMIM>104160</OMIM>
        </Gene>
        <Gene Symbol="INTS5" FullName="integrator complex subunit 5" GeneID="80789" HGNC_ID="HGNC:29352" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62646848" stop="62653302" display_start="62646848" display_stop="62653302" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62414319" stop="62420773" display_start="62414319" display_stop="62420773" Strand="-" />
          </Location>
          <OMIM>611349</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000011.10:g.62628412_62655064del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62395884" stop="62422536" display_start="62395884" display_stop="62422536" variantLength="26653" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.62395884_62422536del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.62395884_62422536del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.10:g.62628412_62655064del AND Polycystic kidney disease 3 with or without polycystic liver disease" Accession="RCV001030766" Version="2">
        <ClassifiedConditionList TraitSetID="31378">
          <ClassifiedCondition DB="MedGen" ID="C3887964">Polycystic kidney disease 3 with or without polycystic liver disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-10-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-10-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-06" MostRecentSubmission="2020-04-06">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32405593</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="31378" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5774" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney disease 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE III</ElementValue>
                <XRef Type="MIM" ID="600666" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Polycystic kidney disease 3 with or without polycystic liver disease</ElementValue>
                <XRef ID="MONDO:0010916" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">APKD3</ElementValue>
                <XRef Type="MIM" ID="600666" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD3</ElementValue>
                <XRef Type="MIM" ID="600666" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased risk of intracranial aneurysms. Other manifestations include: cysts in the pancreas, seminal vesicles, and arachnoid membrane; dilatation of the aortic root and dissection of the thoracic aorta; mitral valve prolapse; and abdominal wall hernias. Kidney manifestations include early-onset hypertension, kidney pain, and kidney insufficiency. Approximately 50% of individuals with ADPKD have end-stage kidney disease (ESKD) by age 60 years. The prevalence of liver cysts increases with age and occasionally results in clinically significant severe polycystic liver disease (PLD), most often in females. Overall, the prevalence of intracranial aneurysms is fivefold higher than in the general population and further increased in those with a positive family history of aneurysms or subarachnoid hemorrhage. There is substantial variability in the severity of kidney disease and other extra-kidney manifestations.</Attribute>
                <XRef ID="NBK1246" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301424</ID>
                <ID Source="BookShelf">NBK1246</ID>
              </Citation>
              <XRef ID="C3887964" DB="MedGen" />
              <XRef ID="MONDO:0010916" DB="MONDO" />
              <XRef Type="MIM" ID="600666" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1950740" SubmissionDate="2019-10-08" DateLastUpdated="2020-04-06" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="SUB6395444" submittedAssembly="hg19" title="SUB6395444" />
        <ClinVarAccession Accession="SCV000995031" DateUpdated="2020-04-06" DateCreated="2020-04-06" Type="SCV" Version="1" SubmitterName="Stefan Somlo Laboratory, Yale School of Medicine" OrgID="507013" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Patient has polycystic liver disease with a small number of kidney cysts and lacks mutations in other established disease genes. This 26kb deletion removes the majority of the established disease gene GANAB.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>Found by applying XHMM to assess relative read depth from exome sequencing. Confirmed with genomic DNA qPCR and sanger sequencing.</Description>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <Comment>genomic qPCR shows 50% wild type copy number in deletion. Sanger sequence defines deletion allele.</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.62395884_62422536del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600666" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6395444</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1950740" TraitType="Disease" MappingType="XRef" MappingValue="600666" MappingRef="OMIM">
        <MedGen CUI="C3887964" Name="Polycystic kidney disease 3 with or without polycystic liver disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

